Gut microbiota derived metabolites in cardiovascular health and disease

Trillions of microbes inhabit the human gut, not only providing nutrients and energy to the host from the ingested food, but also producing metabolic bioactive signaling molecules to maintain health and elicit disease, such as cardiovascular disease (CVD). CVD is the leading cause of mortality worldwide. In this review, we presented gut microbiota derived metabolites involved in cardiovascular health and disease, including trimethylamine-N-oxide (TMAO), uremic toxins, short chain fatty acids (SCFAs), phytoestrogens, anthocyanins, bile acids and lipopolysaccharide. These gut microbiota derived metabolites play critical roles in maintaining a healthy cardiovascular function, and if dysregulated, potentially causally linked to CVD. A better understanding of the function and dynamics of gut microbiota derived metabolites holds great promise toward mechanistic predicative CVD biomarker discoveries and precise interventions.     

Gut microbiota,host health,and polysaccharides

The intestinal microbiota is a complicated ecosystem that influences many aspects of host physiology (i.e. diet, disease development, drug metabolism, and regulation of the immune system). It also exhibits spatial patterning and temporal dynamics. In this review, the effects of internal and external (environmental) factors on intestinal microbiota are discussed. We describe the roles of the gut microbiota in maintaining intestinal and immune system homeostasis and the relationship between gut microbiota and diseases. In particular, the contributions of polysaccharides, as the most abundant diet components in intestinal microbiota and host health are presented. Finally, perspectives for research avenues relating to gut microbiota are also discussed.     

Gut microbiota bridges the iron homeostasis and host health

The gut microbiota acts as a symbiotic microecosystem that plays an indispensable role in the regulation of a number of metabolic processes in the host by secreting secondary metabolites and impacting the physiology and pathophysiology of numerous organs and tissues through the circulatory system. This relationship, referred to as the “gut-X axis”, is associated with the development and progression of disorders, including obesity, fatty liver and Parkinson’s disease. Given its importance, the gu...     

肠道菌群与肝癌

肝癌是世界上最恶性的疾病之一,发病率居世界第六位,病死率居世界第四位。尽管近年来在肝癌的诊断和治疗方面取得了进展,但患者生存率和术后复发率仍然不尽人意。肠道菌群栖息于人类的消化道,介导人体内多种代谢反应,协助机体完成正常生命活动。目前大量的研究证实,慢性肝病患者（如酒精性肝炎、非酒精性脂肪性肝病和病毒性肝炎等）体内均存在一定程度的肠道菌群紊乱且与疾病的发生发展相关,可能是慢性肝病向肝癌进展的主要因素,因此靶向肠道菌群的诊疗手段可能为肝癌患者的治疗提供新的思路。在此基础上,本文总结大量相关文献,从肠道菌群促进肝癌的机制及其对肝癌的预防、诊断以及治疗等方面进行综述。

     

肠道菌群与神经精神疾病

人体肠道中存在着数量庞大和种类繁多的细菌,这些细菌及其代谢产物在代谢、免疫、内分泌、神经等方面起着重要作用,对于人类的健康有着重要影响。近年来越来越多的研究表明,正常的肠道菌群在维持大脑的发育与功能方面扮演着重要角色,而肠道菌群的失调与一些神经精神疾病密切相关,例如帕金森症、多发性硬化、抑郁、自闭症等。本文就肠道菌群与神经精神疾病的关系作一综述。     

肠道菌群与过敏性哮喘

近年来随着过敏性哮喘发病率的持续升高,人们开始注意到环境、生活方式的改变可能会影响过敏性哮喘的发生。流行病学调查显示,过敏性哮喘的发生和发展与生命早期肠道菌群的紊乱密切相关。本研究主要综述近年来肠道菌群对过敏性哮喘发生的影响及机制,探讨影响肠道菌群定植的主要因素,以及微生态调节剂在过敏性哮喘等变应性疾病中的预防和治疗作用。     

胰腺疾病的肠道微生物群研究进展

肠道微生物群是指存在于人体消化道内的微生物组成的复杂群落。随着16S rRNA基因测序和宏基因组测序等高通量测序技术的发展,肠道微生物群已被证明与多种疾病息息相关。三大胰腺疾病与肠道微生物群密切相关,急性胰腺炎（acute pancreatitis,AP）、慢性胰腺炎（chronic pancreatitis,CP）和胰腺癌患者肠道微生物群的构成和丰度均与健康人群不同。反之,肠道微生物群的改变会减慢或加速胰腺疾病的发生发展。益生菌和抗菌药物的使用及粪菌移植等可减轻胰腺炎症反应,缓解胃肠道症状,影响胰腺癌化疗和免疫治疗的效果,因此可为胰腺疾病的诊疗提供新策略。本文总结了AP、CP和胰腺癌的肠道微生物群研究,阐述了疾病发生时肠道微生物群的变化、与胰腺相互作用的机制以及目前的主要研究技术,探讨了肠道微生物群在胰腺疾病诊疗中的研究进展。

     

肠道菌群与代谢综合征研究进展

代谢综合征是导致心脑血管疾病的危险因素之一,被认为是威胁全球人类健康的公共卫生问题。肠道菌群紊乱与肥胖、2型糖尿病及非酒精性脂肪性肝病等代谢性疾病的相关性已被普遍接受,因此肠道菌群调控有望成为治疗代谢综合征的新靶点。本文对肠道菌群与代谢综合征的关系、肠道菌群影响代谢综合征的可能机制以及与肠道菌群相关的调控策略作一综述。

     

病毒感染性疾病与肠道微生物关系研究进展

肠道微生物影响着人体的营养、代谢、免疫等多种生理活动,对人体健康有非常重要的影响.目前的研究表明,肠道微生物在病毒感染性疾病的感染及预后过程中发挥着重要的作用.本文分别总结了肠道病毒感染、非肠道病毒感染与肠道微生物的相互作用关系以及微生态调节干预病毒感染等内容,以期为相关研究的进一步深入和病毒感染性疾病的防治提供新思路...     

肠道微生物群与抑郁症和肝性脑病

肠道细菌种类繁多,在正常情况下,肠道微生物群之间、肠道微生物群与宿主之间始终处于一个动态的生态平衡状态。如果这种平衡被打破,那么肠道微生物群将会导致疾病的产生。肠道微生物群通过免疫、神经内分泌和生化等途径影响人类的中枢神经系统。目前发现肠道微生物群与抑郁症、肝性脑病等一些神经系统疾病存在联系。     

肠道微生物与自闭症谱系障碍

自闭症谱系障碍(autism spectrum disorder,ASD)是一种精神致残的重要疾病,严重影响儿童身心健康,给家庭和社会带来沉重的负担。患者常出现不同程度胃肠道症状和伴有肠道微生物组成的改变,以此为切入点,近年越来越多的研究聚焦于ASD和肠道微生物的关系上。本文介绍了肠道微生物组成、肠―脑轴及ASD患者肠道微生物的主要变化,并从多个方面阐述了ASD与肠道微生物的关系。     

肠道菌群与中枢神经系统相互作用及相关疾病

肠道菌群参与宿主的多项生理过程,包括营养物质吸收、代谢及免疫系统的发育成熟、抵抗外来病原体入侵等,新的研究显示肠道菌群通过神经、内分泌、代谢和免疫的途径参与了肠道和中枢神经系统的双向调节。肠道菌群的变化与自闭症、多发性硬化、帕金森病、焦虑和抑郁症等一系列神经精神疾病有关,通过改善肠道菌群的微生态疗法有望成为治疗和预防一些神经系统疾病的有效措施。     

蜜蜂肠道微生物研究进展

蜜蜂是全球范围内重要的授粉昆虫,具有很高的经济、生态效益。但是蜜蜂一生中可能会遇到许多挑战。肠道微生物与蜜蜂的健康息息相关,不仅在营养物质的消化吸收方面有重要作用,而且还能抵抗某些病原菌的侵袭以及增强机体免疫力。近年出现的蜜蜂大量死亡现象可能与肠道微生物失调有关。生物以及非生物的因素都可能密切影响着蜜蜂肠道微生物的存活,导致宿主生理功能紊乱甚至死亡。本文综述了蜜蜂的肠道核心微生物组成、分布、变化、影响因素以及主要作用和研究方法,为肠道微生物的研究和利用提供参考。     

Endocrine organs of cardiovascular diseases: Gut microbiota

Gut microbiota (GM) is a collection of bacteria, fungi, archaea, viruses and protozoa, etc. They inhabit human intestines and play an essential role in human health and disease. Close information exchange between the intestinal microbes and the host performs a vital role in digestion, immune defence, nervous system regulation, especially metabolism, maintaining a delicate balance between itself and the human host. Studies have shown that the composition of GM and its metabolites are firmly related to the occurrence of various diseases. More and more researchers have demonstrated that the intestinal microbiota is a virtual ‘organ’ with endocrine function and the bioactive metabolites produced by it can affect the physiological role of the host. With deepening researches in recent years, clinical data indicated that the GM has a significant effect on the occurrence and development of cardiovascular diseases (CVD). This article systematically elaborated the relationship between metabolites of GM and its effects, the relationship between intestinal dysbacteriosis and cardiovascular risk factors, coronary heart disease, myocardial infarction, heart failure and hypertension and the possible pathogenic mechanisms. Regulating the GM is supposed to be a potential new therapeutic target for CVD.     

Gut microbiota in reintroduction of giant panda

Reintroduction is a key approach in the conservation of endangered species. In recent decades, many reintroduction projects have been conducted for conservation purposes, but the rate of success has been low. Given the important role of gut microbiota in health and diseases, we questioned whether gut microbiota would play a crucial role in giant panda's wild‐training process. The wild procedure is when captive‐born babies live with their mothers in a wilderness enclosure and learn wilderness survival skills from their mothers. During the wild‐training process, the baby pandas undergo wilderness survival tests and regular physical examinations. Based on their performance through these tests, the top subjects (age 2–3 years old) are released into the wild while the others are translocated to captivity. After release, we tracked one released panda (Zhangxiang) and collected its fecal samples for 5 months (January 16, 2013 to March 29 2014). Here, we analyzed the Illumina HiSeq sequencing data (V4 region of 16S rRNA gene) from captive pandas (n = 24), wild‐training baby pandas (n = 8) of which 6 were released and 2 were unreleased, wild‐training mother pandas (n = 8), one released panda (Zhangxiang), and wild giant pandas (n = 18). Our results showed that the gut microbiota of wild‐training pandas is significantly different from that of wild pandas but similar to that of captive ones. The gut microbiota of the released panda Zhangxiang gradually changed to become similar to those of wild pandas after release. In addition, we identified several bacteria that were enriched in the released baby pandas before release, compared with the unreleased baby pandas. These bacteria include several known gut‐health related beneficial taxa such as Roseburia, Coprococcus, Sutterella, Dorea, and Ruminococcus. Therefore, our results suggest that certain members of the gut microbiota may be important in panda reintroduction.     

肠道微生态系统及其与宿主的协同进化

肠道微生态系统是寄生在宿主肠道内的微生物的总和。微生物进入肠道后,通过一个复杂的过程形成群落,与宿主之间相互作用,形成共生关系。宿主客观上为微生物提供生存和进化场所,微生态系统为宿主提供营养物质、刺激肠道组织的发育、刺激宿主肠道免疫系统的发育、影响宿主能量代谢、协助宿主降解有毒物质、影响宿主生殖活动和寿命等功能。作为一个进化的系统,微生态系统的物种多样性和丰富度对维持宿主正常生理功能具有重要作用,但同时又受宿主的影响,物种间相互作用和宿主-微生物间的相互作用是微生态系统进化的动力。进化主要表现在微生物和宿主基因组上发生适应性变化。因此,系统生态学的理论对理解肠道微生态系统的运行机制和临床应用具有重要指导作用。     

Autophagy: in sickness and in health

The degradation of intracellular components in lysosomes (autophagy) has recaptured the attention of cell biologists in recent years. The main reason for this renewed interest is the dissection of the molecular machinery that participates in this process, because the identification of new intracellular elements involved in autophagy has provided new tools to trace, quantify and manipulate autophagy in a growing number of organisms. As a result, a better understanding of the physiological roles of autophagy, the consequences of its malfunctioning and its participation in different pathological processes has emerged. This article reviews our current knowledge of the role of autophagy in disease and the efforts to reconcile its proposed dual function as both a cell protector and a cell killer.     

Gut microbiota and aging-A focus on centenarians

Gut microbiota (GM) is a dynamic organ throughout the lifespan. Aging is a complex process that comprises a plethora of mechanisms such as senescence, immunosenescence and inflammaging, representing important pathways of age-related diseases. GM structure could both influence and be influenced by aging occurring changes within the host. A unique category of long living individuals exists, namely centenarians that have the outstanding capacity to adapt to various challenges. Longevity seems to be associated with certain GM which, among other factors, might render individuals more resistant to age-related diseases and subsequently to long living. Diet, prebiotics, probiotics and synbiotics may contribute to longevity through GM modulating. Currently, the exact mechanisms of the association between GM and the host in relation with extended lifespan remain unknown and should be further investigated.